nicotine has been researched along with dehydrocrenatidine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YJ; Hou, PY; Huang, CY; Huang, MT; Li, CL; Pai, HT; Tu, SL; Wang, CC | 1 |
1 other study(ies) available for nicotine and dehydrocrenatidine
| Article | Year |
|---|---|
The Natural Compound Dehydrocrenatidine Attenuates Nicotine-Induced Stemness and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma by Regulating a7nAChR-Jak2 Signaling Pathways.
Topics: Animals; Carbolines; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Liver Neoplasms; Mice; Nicotine; Signal Transduction | 2022 |